Review of Clinical Recommendations for Kawasaki Disease/Syndrome

The article presents the detailed key provisions of the clinical recommendations on providing medical care to children with Kawasaki syndrome/illness, developed by the professional association of pediatric specialists — the Union of Pediatricians of Russia. The current data on the prevalence of pathology is presented, the characteristic diagnostic signs of the disease are given that allow to make a diagnosis as soon as possible and immediately appoint a specific treatment. Therapeutic measures carried out in the required volume determine the further prognosis. The comprehensive approach to the management of pediatric patients with this nosology presented in the article will ensure a high level of medical care quality provided to children with Kawasaki syndrome.

vascular aneurysms, arteritis, Kawasaki syndrome/disease, vasculitis, intravenous immunoglobulin, children, myocardial infarction, coronaritis, coronary arteries, lymphonodular syndrome, systemic disease, mucocutaneous lymphonodular syndrome, vascular stenoses

1. Rowley AH, Baker SC, Shulman ST, et al. Ultrastructural, immunofluorescence, and RNA evidence support the hypothesis of a «new» virus associated with Kawasaki disease. J Infect Dis. 2011;203(7):1021–1030. doi: 10.1093/infdis/jiq136.

2. Burgner D, Davila S, Breunis WB, et al. A genome-wide association study identifies novel and functionally related susceptibility Loci for Kawasaki disease. PLoS Genet. 2009;5(1):e1000319. doi: 10.1371/journal.pgen.1000319.

3. Khor CC, Davila S, Shimizu C, et al. Genome-wide linkage and association mapping identify susceptibility alleles in ABCC4 for Kawasaki disease. J Med Genet. 2011;48(7):467–472. doi: 10.1136/jmg.2010.086611.

4. Mamtani M, Matsubara T, Shimizu C, et al. Association of CCR2-CCR5 haplotypes and CCL3L1 copy number with Kawasaki Disease, coronary artery lesions, and IVIG responses in Japanese children. PLoS ONE. 2010;7;5(7):e11458. doi: 10.1371/journal.pone.0011458.

5. Onouchi Y. [Susceptibility genes for Kawasaki disease. (In Japanese).] Nihon Rinsho. 2014;72(9):1554–1560.

6. Nakamura Y, Yashiro M, Uehara R, et al. Epidemiologic features of Kawasaki disease in Japan: results of the 2007–2008 nationwide survey. J Epidemiol. 2010;20(4):302–307. doi: 10.2188/jea. je20090180.

7. cdc.gov [Internet]. Centers for Disease Control and Prevention. Kawasaki Disease [cited 2017 Mar 17]. Available from: http://www. cdc.gov/kawasaki/.

8. Huang WC, Huang LM, Chang IS, et al. Epidemiologic features of Kawasaki disease in Taiwan, 2003–2006. Pediatrics. 2009;123(3):e401–405. doi: 10.1542/peds.2008-2187.

9. Harnden A, Mayon-White R, Perera R, et al. Kawasaki disease in England: ethnicity, deprivation, and respiratory pathogens. Pediatr Infect Dis J. 2009;28(1):21–24. doi: 10.1097/inf.0b013e 3181812ca4.

10. Баранов А.А., Таточенко В.К., Бакрадзе М.Д. Лихорадочные синдромы у детей. Рекомендации по диагностике и лечению. — М.: Союз педиатров России; 2011. — 208 с. [Baranov AA, Tatochenko VK, Bakradze MD. Likhoradochnye sindromy u detei. Rekomendatsii po diagnostike i lecheniyu. Moscow: Soyuz pediatrov Rossii; 2011. 208 p. (In Russ).]

11. Лыскина Г.А., Ширинская О.Г. Слизисто-кожный лимфонодулярный синдром (синдром Кавасаки). Диагностика и лечение. — М.: ВИДАР; 2008. — 140 с. [Lyskina GA, Shirinskaya OG. Slizistokozhnyi limfonodulyarnyi sindrom (sindrom Kavasaki). Diagnostika i lechenie. Moscow: VIDAR; 2008. 140 p. (In Russ).]

12. Брегель Л.В., Субботин В.М., Солдатова Т.А., и др. Эпидемиологические особенности болезни Кавасаки в Иркутской области: результаты многолетних наблюдений // Педиатрия. Журнал им. Г.Н. Сперанского. — 2011. — Т. 90. — № 5. — С. 49–53. [Bregel’ LV, Subbotin VM, Soldatova TA, et al. Epidemiologicheskie osobennosti bolezni Kavasaki v Irkutskoi oblasti: rezul’taty mnogoletnikh nablyudenii. Pediatriia. 2011;90(5):49–53. (In Russ).]

13. Ozen S, Ruperto N, Dillon MJ, et al. EULAR/PReS endorsed consensus criteria for the classification of childhood vasculitides. Ann Rheum Dis. 2006;65(7):936–941. doi: 10.1136/ard.2005.046300.

14. JCS Joint Working Group. Guidelines for Diagnosis and Management of Cardiovascular Sequelae in Kawasaki Disease (JCS 2013) Digest version. Circ J. 2014;78(10):2521–2562. doi: 10.1253/circj.CJ-66-0096.

15. Лыскина Г.А., Виноградова О.И., Ширинская О.Г., и др. Клиника, диагностика и лечение синдрома Кавасаки. Клинические рекомендации. — М.: Всероссийская общественная организация Ассоциация детских кардиологов России; 2011. — 57 с. [Lyskina GA, Vinogradova OI, Shirinskaya OG, et al. Klinika, diagnostika i lechenie sindroma Kavasaki. Klinicheskie rekomendatsii. Moscow: Vserossiiskaya obshchestvennaya organizatsiya Assotsiatsiya detskikh kardiologov Rossii; 2011. 57 p. (In Russ).]

16. Baker AL, Lu M, Minich LL, et al. Associated symptoms in the ten days before diagnosis of Kawasaki disease. J Pediatr. 2009; 154(4):592–595. doi: 10.1016/j.jpeds.2008.10.006.

17. Valentini P, Ausili E, Schiavino A, et al. Acute cholestasis: atypical onset of Kawasaki disease. Dig Liver Dis. 2008;40(7):582–584. doi: 10.1016/j.dld.2007.10.010.

18. Zulian F, Falcini F, Zancan L, et al. Acute surgical abdomen as presenting manifestation of Kawasaki disease. J Pediatr. 2003;142(6):731–735. doi: 10.1067/mpd.2003.232.

19. Kato H, Sugimura T, Akagi T, et al. Long-term consequences of Kawasaki disease. A 10- to 21-year follow-up study of 594 patients. Circulation. 1996;94(6):1379–1385. doi: 10.1161/01.cir.94.6.1379.

20. Rowley AH, Gonzalez-Crussi F, Gidding SS, et al. Incomplete Kawasaki disease with coronary artery involvement. J Pediatr. 1987;110(3):409–413. doi: 10.1016/s0022-3476(87)80503-6.

21. Papadodima SA, Sakelliadis EI, Goutas ND, et al. Atypical kawasaki disease presenting with symptoms from the genitourinary system: an autopsy report. J Trop Pediatr. 2009;55(1):55–57. doi: 10.1093/tropej/fmn065.

22. Sasaki T, Miyata R, Hatai Y, et al. Hounsfield unit values of retropharyngeal abscess-like lesions seen in Kawasaki disease. Acta Otolaryngol. 2014;134(4):437–440. doi: 10.3109/ 00016489.2013.878475.

23. Diagnostic guidelines for Kawasaki disease. American Heart Association Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease. Am J Dis Child. 1990;144(11):1218–1219.

24. Uehara R, Nakamura Y, Yanagawa H. Epidemiology of Kawasaki disease in Japan. JMAJ. 2005;48(4):183–193.

25. Newburger JW, Takahashi M, Gerber MA, et al. Diagnosis, treatment, and long-term management of Kawasaki disease: a statement for health professionals from the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association. Pediatrics. 2004;114(6):1708–1733. doi: 10.1542/ peds.2004-2182.

26. Taniuchi S, Masuda M, Teraguchi M, et al. Polymorphism of Fc gamma RIIa may affect the efficacy of gamma-globulin therapy in Kawasaki disease. J Clin Immunol. 2005;25(4):309–313. doi: 10.1007/s10875-005-4697-7.

27. Ogata S, BandoY, Kimura S, et al. The strategy of immune globulin resistant Kawasaki disease: a comparative study of additional immune globulin and steroid pulse therapy. J Cardiol. 2009;53(1):15–19. doi: 10.1016/j.jjcc.2008.08.002.

28. uptodate.com [Internet]. Wolters Kluwer. Evidence-based clinical decision support at the point of care [cited 2017 Mar 17]. Available from: http://www.uptodate.com.

29. Burns JC, Best BM, Mejias A, et al. Infliximab treatment of intravenous immunoglobulin-resistant Kawasaki disease. J Pediatr. 2008;153(6):833–838. doi: 10.1016/j.jpeds.

30. Accomando S, Liotta A, Maggio MC, et al. Infliximab administration effective in the treatment of refractory Kawasaki disease. Pediatr Allergy Immunol. 2010;21(7):1091–1092. doi: 10.1111/j.1399-3038.2010.01029.x.

31. Suzuki H, Terai M, Hamada H, et al. Cyclosporin A treatment for Kawasaki disease refractory to initial and additional intravenous immunoglobulin. Pediatr Infect Dis J. 2011;30(10):871–876. doi: 10.1097/INF.0b013e318220c3cf.

32. Tremoulet AH, Pancoast P, Franco A, et al. Calcineurin inhibitor treatment of intravenous immunoglobulin-resistant Kawasaki disease. J Pediatr. 2012;161(3):506–512. doi: 10.1016/j.jpeds.2012.02.048.

33. Eleftheriou D, Levin M, Shingadia D, et al. Management of Kawasaki disease. Arch Dis Child. 2014;99(1):74–83. doi: 10.1136/ archdischild-2012-302841.

34. Kawasaki Disease. In: Pickering LK, Baker CJ, Kimberlin DW, Long SS, editors. Red Book: 2009 Report of the Committee on Infectious Diseases. 28th ed. Elk Grove Village, IL: American Academy of Pediatrics; 2009. p. 413–418.

35. Linnemann CC Jr, Shea L, Partin JC, et al. Reye’s syndrome: epidemiologic and viral studies, 1963–1974. Am J Epidemiol. 1975; 101:517–526. doi: 10.1093/oxfordjournals.aje.a112123.